Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $98.59 | 4 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Dexcom, Inc. | $35.83 | 1 | $0 (2024) |
| Lilly USA, LLC | $23.93 | 1 | $0 (2024) |
| Novo Nordisk Inc | $20.42 | 1 | $0 (2024) |
| Merck Sharp & Dohme LLC | $18.41 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $98.59 | 4 | Dexcom, Inc. ($35.83) |
All Payment Transactions
4 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/04/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: Diabetes | ||||||
| 05/07/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $35.83 | General |
| Category: Endocrinology | ||||||
| 04/08/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: Diabetes | ||||||
| 03/19/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: VACCINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 7 | 265 | 308 | $59,425 | $16,904 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 93 | 110 | $23,650 | $5,950 | 25.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 73 | 96 | $14,208 | $3,849 | 27.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 27 | 27 | $6,156 | $3,098 | 50.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 26 | 26 | $8,450 | $2,098 | 24.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 16 | 17 | $2,516 | $917.73 | 36.5% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 15 | 15 | $3,180 | $506.25 | 15.9% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 15 | 17 | $1,265 | $485.68 | 38.4% |
About Dr. Ruth Forde, M.D
Dr. Ruth Forde, M.D is a Family Medicine healthcare provider based in Represa, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/12/2008. The National Provider Identifier (NPI) number assigned to this provider is 1598932345.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ruth Forde, M.D has received a total of $98.59 in payments from pharmaceutical and medical device companies, with $98.59 received in 2024. These payments were reported across 4 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($98.59).
As a Medicare-enrolled provider, Forde has provided services to 265 Medicare beneficiaries, totaling 308 services with total Medicare billing of $16,904. Data is available for 1 year (2020–2020), covering 7 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine, Student in an Organized Health Care Education/Training Program
- Location Represa, CA
- Active Since 05/12/2008
- Last Updated 08/30/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1598932345
Products in Payments
- Dexcom G6 Transmitter (Medical Supply) $35.83
- MOUNJARO (Drug) $23.93
- Rybelsus (Drug) $20.42
- GARDASIL (Biological) $18.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.